A study to assess NAV-240 in adult participants with Hidradenitis Suppurativa
EU CTIS ID: 2025-523557-33-00
What this study is testing
The main objective of this study is to determine if NAV-240 works more effectively than a dummy treatment (placebo) for participants with moderate-to-severe HS.
- Therapeutic exploratory (Phase II)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Participants of age ≥18 to ≤70 years at the time of consent.
- Participants must have had stable HS for at least 2 months, with no significant improvement or worsening.
- Have at least 5 AN and inflamed skin lesions in at least 2 different areas of the body, one of which must have moderate to severe symptoms (classified as Hurley Stage II or Hurley Stage III).
- Inadequate response to at least one course of antibiotics, as determined by the study doctor.
You likely can't join if
- Participants have more than 20 draining tunnels.
- Have an active skin infection or inflammatory condition that could make it difficult to properly evaluate HS.
- Has undergone major surgery, including surgery for HS or has plans for major surgery during the study period.
The study team makes the final eligibility decision.
Where it's taking place
- Hungary
- Poland
- Germany
- Bulgaria
- Romania
- Canada
- Georgia
- United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65+ years, 18-64 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hungary; Poland; Germany; Bulgaria; Romania; Canada and 2 more locations. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from EU CTIS. The study team decides eligibility, and your own doctor gives medical advice.